Arthex will be participating in an upcoming DM Drug Developers webinar series organized by the Myotonic Dystrophy Foundation
After the success of 2020's Friday Afternoon Webinar Series, Myotonic Dystrophy Foundation (MDF) will use the same format for opportunities to meet DM Drug Developers. The biotechnology and pharmaceutical partners of the MDF, large and small, working on treatments and a cure for myotonic dystrophy will sit down with their community to share their progress and answer your questions in real time.
Click here to register to our session!
